Literature DB >> 12452743

Quality-of-life assessment in an outpatient parenteral antibiotic program.

Alan F Goodfellow1, Amy O Wai, Luciana Frighetto, Carlo A Marra, Barbara M Ferreira, M Lynn Chase, Ruth E Nicol, Carole A Leong, Sally Tomlinson, Peter J Jewesson.   

Abstract

OBJECTIVE: To measure changes and to identify predictors of change of health-related quality of life (HRQoL) for enrollees into an outpatient parenteral antibiotic therapy (OPAT) program.
METHODS: A multidisciplinary, single-center, prospective investigation was conducted at a 1000-bed Canadian adult tertiary-care teaching hospital. Over a 15-month study period, consenting patients who were enrolled in the OPAT program completed paired Short Form-36 (SF-36) questionnaires within 48 hours prior to discharge from the hospital and again 26-30 days after discharge. Sociodemographic data and clinical variables were also collected for the purpose of determining potential predictors of change in quality of life.
RESULTS: During the study period, 134 patients were enrolled in the OPAT program and 82 completed the paired SF-36 questionnaires. Study participants experienced a significant improvement in 3 SF-36 domains (physical functioning, bodily pain, role emotional) and the mental component summary scale (MCS) scores when they were transferred from the hospital to home setting. The SF-36 scores for all domains and summary scales were lower than the Canadian population average (all p < 0.001). Multiple linear-regression analysis revealed that infectious disease diagnosis and baseline physical component summary scale (PCS) scores were predictors of the change in the PCS score when patients transferred from the hospital to the home setting. Length of hospital stay and baseline MCS scores were predictors of the change in MCS scores when patients transferred from the hospital to the home setting.
CONCLUSIONS: This study reveals that some domains in HRQoL appear to improve 4 weeks after discharge for adults enrolled in an OPAT program and that there are different predictors for changes in physical and mental health.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452743     DOI: 10.1345/aph.1C153

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  8 in total

1.  Health-related quality of life and its association with outcomes of outpatient parenteral antibiotic therapy.

Authors:  Liang En Wee; Mangaikarasi Sundarajoo; Way-Fang Quah; Ahmad Farhati; Jie-Ying Huang; Ying-Ying Chua
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-23       Impact factor: 3.267

2.  Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps.

Authors:  L Saillen; L Arensdorff; E Moulin; R Voumard; C Cochet; N Boillat-Blanco; C Gardiol; S de Vallière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

3.  The Impact of a Standardized Discharge Process on 30-Day Readmissions for Patients on Outpatient Parenteral Antibiotic Treatment.

Authors:  Charnicia E Huggins; Tae Eun Park; Eric Boateng; Cosmina Zeana
Journal:  Hosp Pharm       Date:  2020-12-29

4.  Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.

Authors:  J Kieran; A O'Reilly; J Parker; S Clarke; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-21       Impact factor: 3.267

5.  Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey.

Authors:  E G Muldoon; G M Allison; D Gallagher; D R Snydman; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-01       Impact factor: 3.267

6.  Physical and chemical stability of ceftaroline in an elastomeric infusion device.

Authors:  Farah Al Madfai; Syed Tabish R Zaidi; Long Chiau Ming; Troy Wanandy; Rahul P Patel
Journal:  Eur J Hosp Pharm       Date:  2017-07-24

7.  Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient's perspective: a qualitative study.

Authors:  Marvin A H Berrevoets; Anke J M Oerlemans; Mirjam Tromp; Bart Jan Kullberg; Jaap Ten Oever; Jeroen A Schouten; Marlies E Hulscher
Journal:  BMJ Open       Date:  2018-11-12       Impact factor: 2.692

8.  Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Deborah Williams; Mayo Levering; Sara E Cosgrove
Journal:  Open Forum Infect Dis       Date:  2018-06-20       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.